Our team is heading to ACTRIMS 2/29-3/2 and we look forward to connecting with you! More

News & Blog

Catch the latest

Recent Announcements & Press

Octave® Bioscience, Inc. Receives $10 Million Grant from The Michael J. Fox Foundation to Develop and Validate Multi-Analyte Protein Biomarker Test for Parkinson’s Disease Assessments – Businesswire

Octave®Bioscience, Inc. Gaining Traction Among Clinicians for Proteomic Multiple Sclerosis Test – GeonomeWeb

Octave® Bioscience, Inc. Presents Data Highlighting Application and Impact of its Precision Care Solution at MSMilan2023 – Businesswire

Octave Note

Leveraging Biology for Better Informed Treatment Decisions

Precision Medicine: Biomarkers as an Objective Measure

Octave at ECTRIMS: An Overview of Scientific Research Presented on Our MS Precision Care Solution

Media Library

living well

Being Diagnosed with Multiple Sclerosis

living well

Earliest Stages of Multiple Sclerosis

living well

Is My MS Controlled?